You are here: Industry Insights > Market News > Serbia authorizes third shot of COVID-19 vaccine, minister says

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Serbia authorizes third shot of COVID-19 vaccine, minister says

firstwordpharmaAugust 16, 2021

Tag: Serbia , Sputnik V , COVID-19 Vaccine

Favorites

Serbia's health authorities authorized a third dose of COVID-19 vaccines for people with compromised immune systems, health workers and anyone vaccinated at least six months ago, as reported in the National Post.

Serbia authorizes third shot of COVID-19 vaccine, minister says

Labour minister Darija Kisic Tepavcevic said health authorities would start administering the third dose of vaccines to the immunocompromised from Tuesday.

Serbia is currently using COVID-19 vaccines from Pfizer/BioNtech , Sinopharm, AstraZeneca and Russia's Sputnik V.

Previous:S. Korea urges rapid vaccine supply during protest visit to Moderna

Next:All young people aged 16 and 17 in England to be offered vaccine by next week

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

Biotech NewswireMay 10, 2024

Nucleic Acid Medicines Manufacture, Round 2 call.

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.

Biotech NewswireMay 09, 2024

Glucagon-like peptide-1 (GLP-1) Receptor Agonist Semaglutide in an Oleogel Formulation Using the BrainDos™ Technology Significantly Increases Drug Delivery into Cells

Biotech NewswireMay 09, 2024

Serbia authorizes third shot of COVID-19 vaccine, minister says | Pharmasources.com

On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023

Biotech NewswireMay 09, 2024

Alongside its dynamic growth, Vetter announced that it achieved its sustainability goals for 2023.

Serbia authorizes third shot of COVID-19 vaccine, minister says

Related News

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.

Glucagon-like peptide-1 (GLP-1) Receptor Agonist Semaglutide in an Oleogel Formulation Using the BrainDos™ Technology Significantly Increases Drug Delivery into Cells

On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023

You may like